secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2025-04-04T23:59:59+00:00
Accession:  0000950170-25-051143
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo raises $2.1M in registered direct offering and private placement; existing warrants amended
--------------------------------------------------------------------------------

- Sold 1,764,710 shares of common stock and warrants to purchase up to 3,529,420 shares at $1.19/unit.
- Gross proceeds ~$2.1M; net proceeds ~$1.9M after fees; Roth Capital acted as placement agent.
- Amended existing Dec 2024 warrants: exercise price reduced from $9.53 to $1.19 per share.
- Exercise of new and amended warrants requires stockholder approval; warrants expire 5 years from approval date.
- Proceeds for clinical development of product candidates and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025051143/0000950170-25-051143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025051143/apvo-20250403.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-051143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer